TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer
Clinical trial NCT02586675 · COMPLETED
Trial details
- NCT number
- NCT02586675
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-23
- Primary completion
- 2017-05-08
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.